In addition, compare to cblC-MMA patients with normal cognition, the levels of methylmalonic acid in serum total exosomes (Figure 1D) and neuro-exosomes (Figure 1E) of the cblC-MMA patients with cognitive impairment significantly increased. The gene discussed is CBLC; the disease is Cognitive impairment.